Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 13.55 is 88% above its 5-year average of 7.20, near the high end of its 5-year range (5.14–13.55).
As of the fiscal period ended Tuesday, June 30, 2026. 75.35% above its 12-month average of 7.73.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 13.55.
QUICK RATIO (ACID-TEST)
13.55
QUICK RATIO (ACID-TEST) AVG TTM
7.73
QUICK RATIO (ACID-TEST) AVG 3Y
7.55
QUICK RATIO (ACID-TEST) AVG 5Y
7.20
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+75.35%
CURRENT VS 3Y AVG
+79.63%
CURRENT VS 5Y AVG
+88.31%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.85
median of 440 covered companies
CURRENT VS SECTOR MEDIAN
+375.58%
vs the sector median at left
Aprea Therapeutics, Inc.
Market Cap
$8.37M
Quick Ratio (Acid-Test)
13.55
TTM Avg
7.73
3Y Avg
7.55
5Y Avg
7.20
Market Cap
$8.76M
Quick Ratio (Acid-Test)
7.38
TTM Avg
1.60
3Y Avg
1.43
5Y Avg
7.59
Market Cap
$7.77M
Quick Ratio (Acid-Test)
2.61
TTM Avg
2.11
3Y Avg
2.42
5Y Avg
2.17
Market Cap
$7.75M
Quick Ratio (Acid-Test)
5.86
TTM Avg
2.71
3Y Avg
2.06
5Y Avg
3.31
Market Cap
$9.09M
Quick Ratio (Acid-Test)
0.60
TTM Avg
0.62
3Y Avg
0.79
5Y Avg
1.04
Market Cap
$9.42M
Quick Ratio (Acid-Test)
-71.42
TTM Avg
0.41
3Y Avg
1.44
5Y Avg
1.15
Market Cap
$7.03M
Quick Ratio (Acid-Test)
45.95
TTM Avg
58.73
3Y Avg
40.89
5Y Avg
40.89
Market Cap
$6.88M
Quick Ratio (Acid-Test)
1.52
TTM Avg
3.93
3Y Avg
10.24
5Y Avg
10.80
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aprea Therapeutics, Inc. (APRE) | $8.37M | 13.55 | 7.73 | 7.55 | 7.20 |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $8.76M | 7.38 | 1.60 | 1.43 | 7.59 |
| GT Biopharma, Inc. (GTBP)vs › | $7.77M | 2.61 | 2.11 | 2.42 | 2.17 |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.75M | 5.86 | 2.71 | 2.06 | 3.31 |
| Healthcare Triangle, Inc. (HCTI)vs › | $9.09M | 0.60 | 0.62 | 0.79 | 1.04 |
| HeartSciences Inc. (HSCS)vs › | $9.42M | -71.42 | 0.41 | 1.44 | 1.15 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.03M | 45.95 | 58.73 | 40.89 | 40.89 |
| Ainos, Inc. (AIMD)vs › | $9.79M | 0.12 | 0.92 | 1.12 | 0.77 |
| Co-Diagnostics, Inc. (CODX)vs › | $6.88M | 1.52 | 3.93 | 10.24 | 10.80 |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.76M | 10.21 | 3.61 | 3.34 | 4.20 |
Quick Ratio
13.55
Excludes inventory
Current Ratio
13.55
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 13.55 |
| 2026-03-31 | 8.92 |
| 2025-12-31 | 5.63 |
| 2025-09-30 | 5.20 |
| 2025-06-30 | 5.34 |
| 2025-03-31 | 5.90 |
| 2024-12-31 | 7.01 |
| 2024-09-30 | 7.28 |
| 2024-06-30 | 9.55 |
| 2024-03-31 | 11.15 |
| 2023-12-31 | 5.14 |
| 2023-09-30 | 6.15 |
| 2023-06-30 | 7.25 |
| 2023-03-31 | 7.57 |
| 2022-12-31 | 9.42 |
| 2022-09-30 | 8.37 |
| 2022-06-30 | 5.27 |
| 2022-03-31 | 7.45 |
| 2021-12-31 | 7.73 |
| 2021-09-30 | 6.88 |
| 2021-06-30 | 6.73 |
| 2021-03-31 | 7.14 |
| 2020-12-31 | 6.03 |
| 2020-09-30 | 7.49 |
| 2020-06-30 | 7.88 |
| 2020-03-31 | 10.79 |
| 2019-12-31 | 14.68 |
| 2019-09-30 | 5.92 |
| 2019-06-30 | 10.87 |
| 2019-03-31 | 0.00 |
| 2018-12-31 | 13.56 |
| 2018-09-30 | 0.00 |
